Welcome, Guest. Please login or register.
March 22, 2023, 12:13:04 am

Login with username, password and session length

  • Total Posts: 768356
  • Total Topics: 65689
  • Online Today: 104
  • Online Ever: 5484
  • (June 18, 2021, 11:15:29 pm)
Users Online
Users: 0
Guests: 104
Total: 104


Welcome to the POZ Community Forums, a round-the-clock discussion area for people with HIV/AIDS, their friends/family/caregivers, and others concerned about HIV/AIDS.  Click on the links below to browse our various forums; scroll down for a glance at the most recent posts; or join in the conversation yourself by registering on the left side of this page.

Privacy Warning:  Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If you are HIV positive and disclose this in our forums, then it is almost the same thing as telling the whole world (or at least the World Wide Web). If this concerns you, then do not use a username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.

  • The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own physician.

  • All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.

  • Forums members must behave at all times with respect and honesty. Posting guidelines, including time-out and banning policies, have been established by the moderators of these forums. Click here for “Do I Have HIV?” posting guidelines. Click here for posting guidelines pertaining to all other POZ community forums.

  • We ask all forums members to provide references for health/medical/scientific information they provide, when it is not a personal experience being discussed. Please provide hyperlinks with full URLs or full citations of published works not available via the Internet. Additionally, all forums members must post information which are true and correct to their knowledge.

  • Product advertisement—including links; banners; editorial content; and clinical trial, study or survey participation—is strictly prohibited by forums members unless permission has been secured from POZ.

To change forums navigation language settings, click here (members only), Register now

Para cambiar sus preferencias de los foros en español, haz clic aquí (sólo miembros), Regístrate ahora

Finished Reading This? You can collapse this or any other box on this page by clicking the symbol in each box.

Author Topic: EBT-101  (Read 4586 times)

0 Members and 1 Guest are viewing this topic.

Offline MitchMiller

  • Member
  • Posts: 671
« on: September 17, 2021, 09:42:55 pm »
After reading about it for a few years, CRISPR is about to be trialed in humans to excise HIV from cells.  The hope is that enough virus (including latent virus) can be removed from the body to accomplish a functional cure.  It has already worked on primates that have SIV. 


Offline em

  • Member
  • Posts: 686

Offline Jim Allen

  • Administrator
  • Member
  • Posts: 20,517
  • Twitter @JimAllenDublin
    • HIV Lessons
Re: EBT-101
« Reply #2 on: November 05, 2021, 12:04:32 pm »
human trials ,    any thoughts

The same thoughts I had in 2016 about Dr. Khalili work with CRISPR when they cured a mouse and in 2020 on the primate. Scientifically interesting but no other thoughts at such an early stage.

HIV 101 - Everything you need to know
HIV 101
Read more about Testing here:
HIV Testing
Read about Treatment-as-Prevention (TasP) here:
You can read about HIV prevention here:
HIV prevention
Read about PEP and PrEP here
PEP and PrEP

Offline CircularNatural

  • Member
  • Posts: 41
  • 🇦🇷 Joined Sept 2021
Re: EBT-101
« Reply #3 on: November 05, 2021, 04:09:10 pm »
It's so interesting to follow this kind of novel treatments... one can only be hopeful  ;D :D :)
🇦🇷 "Hope is the only thing stronger than fear."

Offline Da2020

  • Member
  • Posts: 41
Re: EBT-101
« Reply #4 on: January 23, 2022, 05:30:43 pm »
They have posted it on clinicaltrails.gov in December and recently updated the trail start date as Jan 2022. If only they would start the trail. It is a very interesting approach and trail. They want to start ATI within 3 months which is definitely very interesting

Offline em

  • Member
  • Posts: 686
Re: EBT-101
« Reply #5 on: January 24, 2022, 07:14:59 am »

Offline Da2020

  • Member
  • Posts: 41
Re: EBT-101
« Reply #6 on: February 20, 2022, 08:19:03 pm »
They have started the trail in St.Louis, MO

Offline Da2020

  • Member
  • Posts: 41
Re: EBT-101
« Reply #7 on: May 22, 2022, 04:39:53 pm »
They have presented a poster demonstrating, no off target cuts . At least we know its not going to create zombies :)

Offline geobee

  • Member
  • Posts: 375
Re: EBT-101
« Reply #8 on: May 31, 2022, 12:46:10 am »
Another breathless "milestone" -- demonstrated "efficacy" against HIV.


Offline Da2020

  • Member
  • Posts: 41
Re: EBT-101
« Reply #9 on: May 31, 2022, 02:49:06 pm »
Another breathless "milestone" -- demonstrated "efficacy" against HIV.


They have reaped this news in February, there actually is a separate thread tracking them

Offline Cosmicdancer

  • Member
  • Posts: 197
Re: EBT-101
« Reply #10 on: September 18, 2022, 11:03:09 am »
Excision BioTherapeutics Doses First Participant in EBT-101 Phase 1/2 Trial Evaluating EBT-101 as a Potential Cure for HIV

* EBT-101 is an in vivo CRISPR-based therapeutic designed to remove HIV proviral DNA from affected cell reservoirs

* First-in-human study will evaluate the safety and efficacy of EBT-101 in participants who chronically suppress HIV with daily antiretroviral therapy

* EBT-101 has been well tolerated to-date and the trial is proceeding as planned

SAN FRANCISCO, Sept. 15, 2022 (GLOBE NEWSWIRE) -- Excision BioTherapeutics, Inc., a clinical-stage biotechnology company developing CRISPR-based therapies intended to cure viral infectious diseases, today announced that the first participant has been dosed in the Phase 1/2 clinical trial of EBT-101 for human immunodeficiency virus type 1 (HIV-1). The participant was dosed in July 2022, with initial findings indicating EBT-101 has been well tolerated to-date. The participant continues to be monitored for safety and is expected to qualify for analytical treatment interruption (ATI) of their background anti-retroviral therapy (ART) in an evaluation of a potential cure.

“Dosing the first participant with EBT-101 is a landmark event that solidifies Excision’s position as a pioneer in gene editing,” said Daniel Dornbusch, Chief Executive Officer of Excision. “It is the first time a CRISPR-based therapy targeting an infectious disease has been administered to a patient and is expected to enable the first ever clinical assessment of a multiplexed, in vivo gene editing approach. We were able to reach this watershed moment thanks to years of innovative work by leading scientists and physicians, to whom we are immensely grateful. With this achievement, Excision has taken a major step forward in developing a one-time treatment that could transform the HIV pandemic by freeing affected people from life-long disease management and the stigma of disease."

Summer, 2007 - &$#@?
November, 2007 - Tested poz, 300,000 vl, 560 cd4
Feb, 2008 - 57,000 vl, 520 cd4, started Atripla
2/2008 - 5/2015 - undetectable on Atripla
May, 2015 - UD, switched to Complera
September, 2015 - UD, 980 cd4, switched to Stribild (Complera interacted with acid reflux medication)
January, 2016 - Stribild, UD, 950 cd4
June, 2016 - UD, 929 cd4


Terms of Membership for these forums

© 2023 Smart + Strong. All Rights Reserved.   terms of use and your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.